CD55/DAF Antibody Summary
Immunogen |
Recombinant protein encompassing a sequence within the center region of human CD55. The exact sequence is proprietary.
|
Localization |
Isoform 1: Membrane; Isoform 2: Cell membrane; GPI-anchor
|
Isotype |
IgG
|
Clonality |
Polyclonal
|
Host |
Rabbit
|
Gene |
CD55
|
Purity |
Immunogen affinity purified
|
Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
Dilutions |
|
Application Notes |
The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
|
Theoretical MW |
41 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Packaging, Storage & Formulations
Storage |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
|
Buffer |
PBS (pH 7.0), 1.0% BSA and 20% Glycerol
|
Preservative |
0.01% Thimerosal
|
Concentration |
1 mg/ml
|
Purity |
Immunogen affinity purified
|
Alternate Names for CD55/DAF Antibody
- CD55 antigen
- CD55 molecule, decay accelerating factor for complement (Cromer blood group)
- CD55
- CR
- CRdecay accelerating factor for complement (CD55, Cromer blood group system)
- CROMDAFcomplement decay-accelerating factor
- DAF
- decay accelerating factor for complement
- TC
Background
This gene encodes a protein involved in the regulation of the complement cascade. The encoded glycoprotein is also known as the decay-accelerating factor (DAF); binding of DAF to complement proteins accelerates their decay, disrupting the cascade and preventing damage to host cells. Antigens present on the DAF glycoprotein constitute the Cromer blood group system (CROM). Two alternatively spliced transcripts encoding different proteins have been identified. The predominant transcript encodes a membrane-bound protein expressed on cells exposed to plasma component proteins but an alternatively spliced transcript produces a soluble protein present at much lower levels. Additional, alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq]